[血液造血干细胞基因治疗的未来前景]
1Graduate School of Engineering, The University of Osaka.
[Rinsho ketsueki] The Japanese journal of clinical hematology
|October 1, 2025
概括
造血干细胞基因疗法对遗传性疾病提供了希望. 基因组编辑的进步提供了新的途径,但由于潜在的永久基因组变化,需要仔细的临床开发.
科学领域:
- 生物技术是生物技术.
- 遗传学 是一个遗传学.
- 血液学 血液学 血液学
背景情况:
- 造血干细胞 (HSCs) 具有自我更新和多谱系分化能力.
- HSC基因疗法是对遗传性疾病的潜在治疗方法,为移植提供了替代方案.
- 目前的晶状病毒载体基因疗法已经获得批准,但面临着诸如插入性突变发生和功能增益性疾病的有限疗效等挑战.
研究的目的:
- 探索基因组编辑技术在HSC基因治疗中的潜力.
- 解决现有的基因疗法方法的局限性,包括瘤发生和疗效问题.
- 强调需要对基因组编辑疗法进行谨慎的临床开发.
主要方法:
- 审查使用造血干细胞的当前基因疗法策略.
- 分析与lentiviral载体基因疗法相关的挑战.
- 检查治疗应用新兴的基因组编辑技术.
主要成果:
- 使用lentiviral载体的基因疗法已被批准用于某些遗传性疾病.
- 插入性突变发生和功能获取疾病的不充分反应仍然是重大挑战.
- 基因组编辑技术正在成为HSC基因治疗的有希望的替代方案.
结论:
- 基因组编辑提供了一种新的方法来克服当前HSC基因治疗的局限性.
- 永久的基因组改变需要谨慎,社会知情的临床进展.
- 进一步的研究和开发对于基于基因组编辑的安全有效疗法至关重要.
相关概念视频
Multipotency of Hematopoietic Stem Cells
3.8K
The hematopoietic stem cells or HSCs are multipotent, meaning they can differentiate and give rise to all blood and immune cells. HSCs are maintained in the quiescent stage until an external stimulus initiates their differentiation. The multipotent HSCs exist as two heterogeneous populations, long-term repopulating cells (LTRC) and short-term repopulating cells (STRC). The two HSC populations have different surface markers or receptors and are classified based on quiescence and long-term...
3.8K
Stem Cell Therapy for Tissue Regeneration
4.6K
Stem cell therapy is a method used in regenerative medicine to repair and restore function to damaged tissues and organs. Stem cells have the potential to proliferate and differentiate into various tissue types, making them ideal candidates for tissue regeneration. For example, hematopoietic stem cell transplants are commonly used in blood cancer treatment to replenish damaged bone marrow and restore healthy blood cells.
Types of Stem Cells used in Stem Cell Therapy
The two main cell...
Types of Stem Cells used in Stem Cell Therapy
The two main cell...
4.6K
Regulation of Hematopoietic Stem Cells
4.0K
All blood and immune cells are produced from the multipotent hematopoietic stem cells (HSCs) by the process of hematopoiesis. However, they all have a limited life span. In addition, many are depleted in immune surveillance or combatting an injury or infection. This makes blood one of the most regenerative tissues. Hematopoiesis helps replenish these blood and immune cells, restoring the body's normal functioning. However, overproduction of blood and immune cells can make them cancerous or...
4.0K
iPS Cell Differentiation
3.0K
The ability of induced pluripotent stem cells or iPSCs to differentiate into most body cell types has stimulated repair and regenerative medicine research over the past few decades. iPSC-derived blood cells, hepatocytes, beta islet cells, cardiomyocytes, neurons, and other cell types can repair injuries or regenerate damaged tissue in diseases such as diabetes and neurodegenerative disorders.
3.0K
Gene Therapy
27.3K
Gene therapy is a technique where a gene is inserted into a person’s cells to prevent or treat a serious disease. The added gene may be a healthy version of the gene that is mutated in the patient, or it could be a different gene that inactivates or compensates for the patient’s disease-causing gene. For example, in patients with severe combined immunodeficiency (SCID) due to a mutation in the gene for the enzyme adenosine deaminase, a functioning version of the gene can be...
27.3K
Stem Cell Culture
6.0K
Stem cell research aims to find ways to use stem cells to regenerate and repair cellular damage. Over time, most adult cells undergo the wear and tear of aging and lose their ability to divide and repair themselves. Stem cells do not display a particular morphology or function. Adult stem cells, which exist as a small subset of cells in most tissues, keep dividing and can differentiate into a number of specialized cells generally formed by that tissue. These cells enable the body to renew and...
6.0K


